Drug
AZD5718 clinical trials
Also written AZD5718.
- studies test it
- 11
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2020 (3)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 1
AstraZeneca (10) · National University Heart Centre, Singapore (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AZD5718 is read from its arms, and is right about nine times in ten.
Testing it · 11
- Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaCompletedPhase 2AstraZenecaNCT05251259Written as Atuliflapon
- PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromETerminatedPhase 2National University Heart Centre, SingaporeNCT04601467Written as AZD5718
- A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseTerminatedPhase 2AstraZenecaNCT04492722Written as AZD5718
- Study to Assess Relative Bioavailability and Safety of AZD5718 in Healthy VolunteersCompletedPhase 1AstraZenecaNCT04734275Written as AZD5718
- AZD5718 Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of Oral AZD5718 in Patients With Coronary Artery Disease (CAD).CompletedPhase 2AstraZenecaNCT03317002Written as AZD5718
- A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy SubjectsCompletedPhase 1AstraZenecaNCT04492709Written as AZD5718
- A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy VolunteersCompletedPhase 1AstraZenecaNCT04210388Written as AZD5718 tablet, Formulation A
- Study Evaluating the Pharmacokinetic and Mass Balance of Single Dose [14C] AZD5718 in VolunteersCompletedPhase 1AstraZenecaNCT03948451Written as [14C]AZD5718 Oral Suspension
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male SubjectsCompletedPhase 1AstraZenecaNCT02632526Written as AZD5718 oral suspension crystalline form (1 to 100 mg/mL) (Part A)
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese MenCompletedPhase 1AstraZenecaNCT03400488Written as AZD5718 oral suspension
- A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release TabletCompletedPhase 1AstraZenecaNCT02963116Written as AZD5718 IR tablet